Translational Development Acquisition (TDAC) Net Income towards Common Stockholders (2024 - 2026)
Translational Development Acquisition (TDAC) posted Net Income towards Common Stockholders of $283351.0 for Q1 2026, up 111.8% on a QoQ basis from -$2.4 million in Q4 2025, and down 75.74% year-over-year from $1.2 million in Q1 2025.
Translational Development Acquisition (TDAC) Net Income towards Common Stockholders (2024 - 2026) Analysis & Trends
Translational Development Acquisition's Net Income towards Common Stockholders history runs 3 years deep, the most recent figure standing at $283351.0 for Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 75.74% year-over-year to $283351.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $468218.0 (changed N/A YoY) and the FY2025 annual result came in at $1.4 million, up 25392.48% from the prior year.
- Net Income towards Common Stockholders was $283351.0 for Q1 2026 at Translational Development Acquisition, up from -$2.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $1.3 million in Q3 2025 and bottomed at -$2.4 million in Q4 2025.
- A 3-year average of $282268.8 and a median of $725563.0 in 2025 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2025 — Net Income towards Common Stockholders tumbled 4266.15% — and 2026, when it tumbled 75.74%.
- Translational Development Acquisition's Net Income towards Common Stockholders stood at $57620.0 in 2024, then tumbled by 4266.15% to -$2.4 million in 2025, then jumped by 111.8% to $283351.0 in 2026.
- Business Quant data shows TDAC's Net Income towards Common Stockholders at $283351.0 in Q1 2026, -$2.4 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 480.75 Mn | 480.75 Mn | - | 764,684.00 |
| 2 | Agriculture & Natural Solutions Acquisition | 393.29 Mn | 393.29 Mn | - | -612,993.00 |
| 3 | Berto Acquisition | 314.56 Mn | 314.35 Mn | - | 443,750.00 |
| 4 | GP-Act III Acquisition | 313.66 Mn | 313.66 Mn | - | 2.31 Mn |
| 5 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 504,022.00 |
| 6 | Republic Digital Acquisition | 310.50 Mn | 309.63 Mn | - | 2.04 Mn |
| 7 | Siddhi Acquisition Corp (Cayman Islands) | 288.97 Mn | 288.97 Mn | - | 465,276.00 |
| 8 | K&F Growth Acquisition | 283.42 Mn | 283.42 Mn | - | 648,512.00 |
| 9 | Bold Eagle Acquisition | 275.29 Mn | 275.29 Mn | - | 382,994.00 |
| 10 | Translational Development Acquisition | 186.90 Mn | 186.90 Mn | - | 283,351.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 283,351.00 |
| Dec 31, 2025 | -2.40 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 57,620.00 |